drugset / Trial / NCT02799498

Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection

NCT02799498

Phase 1 Completed 36 enrolled Amgen
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare Pharmacokinetics of liquid etanercept that is administered to healthy subjects aged 18-55 by an auto-injector device and manual injection (each subject received both injections).

Timeline

Start
2003-10
Primary completion
2004-01
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etanercept Protein / enzyme biologic 50 mg Subcutaneous

Indications

No indication recorded.